Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of life saving
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    801 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 77
    802 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 23
    803 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 58
    804 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 53
    805 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 75
    806 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 61
    807 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 8
    808 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
    809 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 38
    810 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 70
    811 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 69
    812 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 31
    813 Bone Marrow Family Allogeneic Acute Myleogenous Leukemia, alloPBST 7/2025 Hematology 2025 Standard Therapy Germany 53
    814 Bone Marrow Allogeneic Aplastic Anemia Hematology 2025 Standard Therapy Spain 15
    815 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Norway 55
    816 Bone Marrow Allogeneic Inherited Immune System Disorder Hematology 2025 Standard Therapy France 3
    817 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 7
    818 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Ukraine 36
    819 Bone Marrow Allogeneic Inherited Immune System Disorder Hematology 2025 Standard Therapy France 10
    820 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 76
    821 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 39
    822 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy South Africa 6
    823 Bone Marrow Allogeneic Wiskott-Aldrich syndrome Hematology 2025 Standard Therapy Turkey 6
    824 Bone Marrow Allogeneic Combined immnunodeficiency Hematology 2025 Standard Therapy Ukraine 3 months
    825 Bone Marrow Allogeneic Chronic Granulomatous Disease Hematology 2025 Standard Therapy Poland 3
    826 Bone Marrow Allogeneic Mixed Phenotype Acute Leukemia Hematology 2025 Standard Therapy Poland 13
    827 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 7
    828 Bone Marrow Allogeneic B-cell precursor Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 56
    829 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 43
    830 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 19
    831 Bone Marrow Allogeneic Very Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 12
    832 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 5
    833 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 10 months
    834 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 6
    835 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 44
    836 Bone Marrow Allogeneic Paroxysmal Nocturnal Hemoglobinuria Hematology 2025 Standard Therapy Poland 25
    837 Bone Marrow Allogeneic Juvenile Myelomonocytic Leukemia Hematology 2025 Standard Therapy Poland 4
    838 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy USA 21
    839 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 12
    840 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Hungary 10
    841 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 68
    842 Bone Marrow Allogeneic Adrenoleukodystrophy Hematology 2025 Standard Therapy Poland 53
    843 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 4
    844 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy France 4
    845 Bone Marrow Allogeneic Paroxysmal Nocturnal Hemoglobinuria Hematology 2025 Standard Therapy Norway 18
    846 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Spain 24
    847 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Belarus 5
    848 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Germany 53
    849 Bone Marrow Allogeneic diamond-Balckfan anemia Hematology 2025 Standard Therapy Germany 11
    850 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 57
    851 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 61
    852 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy France 3
    853 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Belarus 1
    854 Bone Marrow Allogeneic pB-Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 15
    855 Bone Marrow Allogeneic OHID XIAP – Other Histiocytic Disorders / X-Linked Inhibitor of Apoptosis Protein Hematology 2025 Standard Therapy Switzerland 2
    856 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 46
    857 Bone Marrow Allogeneic Acquired Idiopathic Sideroblastic Anemia Hematology 2025 Standard Therapy Russian Federation 5
    858 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 10
    859 Bone Marrow Allogeneic Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 47
    860 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy CROATIA 11
    861 Bone Marrow Allogeneic Juvenile myelomonocytic leukemia Hematology 2025 Standard Therapy Poland 5
    862 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Brazil 12
    863 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Australia 8
    864 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 3
    865 Bone Marrow Allogeneic Myelodysplatic Syndrome Hematology 2025 Standard Therapy USA 60
    866 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russia 36
    867 Bone Marrow Allogeneic Thalassemia major Hematology 2025 Standard Therapy Turkey 10
    868 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 58
    869 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 2
    870 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy USA 18
    871 Bone Marrow Allogeneic Other Non-Malignant Disease, Specify Hematology 2025 Standard Therapy USA 17
    872 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 15
    873 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 15
    874 Bone Marrow Allogeneic aplastic anemia Hematology 2025 Standard Therapy Belgium 36
    875 Bone Marrow Allogeneic Primary Refractory Hematology 2025 Standard Therapy Ireland 27
    876 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 39
    877 Bone Marrow Allogeneic Sickle Cell Disease (SCD) Hematology 2025 Standard Therapy Italy 8
    878 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 68
    879 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 58
    880 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 1
    881 Bone Marrow Allogeneic Severe Combined Immunodeficiency Hematology 2025 Standard Therapy United Kingdom 13
    882 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Denmark 38
    883 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 17
    884 Bone Marrow Allogeneic Fanconi Anemia Hematology 2025 Standard Therapy Poland 11
    885 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 9
    886 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 3
    887 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy France 9
    888 Bone Marrow Allogeneic Fanconi Anemia  Hematology 2025 Standard Therapy Poland 8
    889 Bone Marrow Allogeneic Immune Deficiency Hematology 2025 Standard Therapy United Kingdom 10
    890 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 12
    891 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy USA 20
    892 Bone Marrow Allogeneic Hodgkin Lymphoma Hematology 2025 Standard Therapy Turkey 17
    893 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 13
    894 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Canada 22
    895 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 15
    896 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Italy 8
    897 Bone Marrow Allogeneic Inherited Immune System Disorder Hematology 2025 Standard Therapy France 3
    898 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 2
    899 Bone Marrow Allogeneic Bone Marrow Failure Hematology 2025 Standard Therapy Netherlands 23
    900 Bone Marrow Allogeneic Chronic Granulomatous Disease Hematology 2025 Standard Therapy Italy 6